ASMR

Conclusion • DIBH implementation in lymphoma very succesful • Protocol in lung cancer patients ongoing

• Clear dosimetric benefit, even when using VMAT/IMRT

• Ressource investment: the ”sore points” are • PET scanning time • IGRT • And even then, they remain very manageable !